Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jul;69(1):204–212.

Aberrant phagocyte function in Shwachman syndrome.

H Repo 1, E Savilahti 1, M Leirisalo-Repo 1
PMCID: PMC1542243  PMID: 3652529

Abstract

Polymorphonuclear leucocytes (PMN) of patients with Shwachman syndrome show impaired mobility in vitro. We took this finding a step further by studying chemotaxis and chemiluminescence responses of purified PMN and monocytes (MO) of seven patients with Shwachman syndrome. Chemiluminescence responses of the patients' PMN were significantly increased, and thus impaired mobility may have derived from auto-oxidation of PMN. Chemotaxis of purified PMN was not impaired in a membrane filter, but it did become impaired when PMN were remixed with autologous mononuclear (MN) cells or MO. These cells always increased the migration of PMN. Because the patients' cells were fully capable of increasing the migration of control PMN, the defect most probably involved PMN. This is in harmony with the finding that the patients' purified PMN showed depressed chemotaxis under agarose. This suggests that for detecting impaired chemotaxis of purified PMN the assay conditions were more optimal in the agarose test than in the filter test. Both chemotaxis and chemiluminescence responses of the patients' MO were depressed, and thus, the defects involving PMN and MO are separate.

Full text

PDF
206

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggett P. J., Cavanagh N. P., Matthew D. J., Pincott J. R., Sutcliffe J., Harries J. T. Shwachman's syndrome. A review of 21 cases. Arch Dis Child. 1980 May;55(5):331–347. doi: 10.1136/adc.55.5.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aggett P. J., Harries J. T., Harvey B. A., Soothill J. F. An inherited defect of neutrophil mobility in Shwachman syndrome. J Pediatr. 1979 Mar;94(3):391–394. doi: 10.1016/s0022-3476(79)80578-8. [DOI] [PubMed] [Google Scholar]
  3. Al-Sumidaie A. M., Jones D. L., Young H. L. Characterisation of the under-agarose method for quantifying migration of highly purified human monocytes. J Immunol Methods. 1984 Dec 14;75(1):129–140. doi: 10.1016/0022-1759(84)90232-1. [DOI] [PubMed] [Google Scholar]
  4. Babior B. M. Oxidants from phagocytes: agents of defense and destruction. Blood. 1984 Nov;64(5):959–966. [PubMed] [Google Scholar]
  5. Baehner R. L., Boxer L. A., Allen J. M., Davis J. Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood. 1977 Aug;50(2):327–335. [PubMed] [Google Scholar]
  6. Brestel E. P. Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescence. Biochem Biophys Res Commun. 1985 Jan 16;126(1):482–488. doi: 10.1016/0006-291x(85)90631-x. [DOI] [PubMed] [Google Scholar]
  7. Burchill B. R., Oliver J. M., Pearson C. B., Leinbach E. D., Berlin R. D. Microtubule dynamics and glutathione metabolism in phagocytizing human polymorphonuclear leukocytes. J Cell Biol. 1978 Feb;76(2):439–447. doi: 10.1083/jcb.76.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DeChatelet L. R., Long G. D., Shirley P. S., Bass D. A., Thomas M. J., Henderson F. W., Cohen M. S. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol. 1982 Oct;129(4):1589–1593. [PubMed] [Google Scholar]
  9. Graft D. F., Mischler E., Farrell P. M., Busse W. W. Granulocyte chemiluminescence in adolescent patients with cystic fibrosis. Am Rev Respir Dis. 1982 May;125(5):540–543. doi: 10.1164/arrd.1982.125.5.540. [DOI] [PubMed] [Google Scholar]
  10. Kownatzki E., Kapp A., Uhrich S. Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol. 1986 Apr;64(1):214–222. [PMC free article] [PubMed] [Google Scholar]
  11. Luger T. A., Stadler B. M., Luger B. M., Sztein M. B., Schmidt J. A., Hawley-Nelson P., Grabner G., Oppenheim J. J. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol. 1983 Sep;81(3):187–193. doi: 10.1111/1523-1747.ep12517658. [DOI] [PubMed] [Google Scholar]
  12. McPhail L. C., Snyderman R. Mechanisms of regulating the respiratory burst in leukocytes. Contemp Top Immunobiol. 1984;14:247–281. doi: 10.1007/978-1-4757-4862-8_9. [DOI] [PubMed] [Google Scholar]
  13. Nath J., Flavin M., Gallin J. I. Tubulin tyrosinolation in human polymorphonuclear leukocytes: studies in normal subjects and in patients with the Chediak-Higashi syndrome. J Cell Biol. 1982 Nov;95(2 Pt 1):519–526. doi: 10.1083/jcb.95.2.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nelson R. D., McCormack R. T., Fiegel V. D., Herron M., Simmons R. L., Quie P. G. Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun. 1979 Feb;23(2):282–286. doi: 10.1128/iai.23.2.282-286.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Repo H., Leirisalo M., Tiilikainen A., Laitinen O. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Arthritis Rheum. 1982 Jun;25(6):655–661. doi: 10.1002/art.1780250608. [DOI] [PubMed] [Google Scholar]
  16. Rocklin R. E., Bendtzen K., Greineder D. Mediators of immunity: lymphokines and monokines. Adv Immunol. 1980;29:55–136. doi: 10.1016/s0065-2776(08)60043-7. [DOI] [PubMed] [Google Scholar]
  17. Ruutu P., Savilahti E., Repo H., Kosunen T. U. Constant defect in neutrophil locomotion but with age decreasing susceptibility to infection in Shwachman syndrome. Clin Exp Immunol. 1984 Jul;57(1):249–255. [PMC free article] [PubMed] [Google Scholar]
  18. SHWACHMAN H., DIAMOND L. K., OSKI F. A., KHAW K. T. THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr. 1964 Nov;65:645–663. doi: 10.1016/s0022-3476(64)80150-5. [DOI] [PubMed] [Google Scholar]
  19. Savilahti E., Rapola J. Frequent myocardial lesions in Shwachman's syndrome. Eight fatal cases among 16 Finnish patients. Acta Paediatr Scand. 1984 Sep;73(5):642–651. doi: 10.1111/j.1651-2227.1984.tb09989.x. [DOI] [PubMed] [Google Scholar]
  20. Szüts P., Katona Z., Ilyés M., Szabó I., Csató M. Correction of defective chemotaxis with thiamine in Shwachman-Diamond syndrome. Lancet. 1984 May 12;1(8385):1072–1073. doi: 10.1016/s0140-6736(84)91476-4. [DOI] [PubMed] [Google Scholar]
  21. Terui T., Kato T., Suzuki R., Kumagai K., Tagami H. Effect of interleukin 1 on chemotaxis and chemiluminescence of human neutrophils. Tohoku J Exp Med. 1986 Jul;149(3):317–322. doi: 10.1620/tjem.149.317. [DOI] [PubMed] [Google Scholar]
  22. Thurnham D. I. Antimalarial effects of riboflavin deficiency. Lancet. 1985 Dec 7;2(8467):1310–1311. doi: 10.1016/s0140-6736(85)91598-3. [DOI] [PubMed] [Google Scholar]
  23. Valone F. H. Regulation of human leukocyte function by lipoxygenase products of arachidonic acid. Contemp Top Immunobiol. 1984;14:155–170. doi: 10.1007/978-1-4757-4862-8_5. [DOI] [PubMed] [Google Scholar]
  24. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES